BridgeMD
Compares treatment options for Adhesive Capsulitis
Official title Bowen Technique Versus Dynamic Soft Tissue Mobilization on Pain, Range of Motion and Functional Disability in Patients With Adhesive Capsulitis
ClinicalTrials.gov ID: NCT07047846
What this study is testing
- What it's testing
- A randomized controlled trial included 72 patients diagnosed with adhesive capsulitis will conduct in University of Lahore Teaching Hospital. The study will complete within 9 months after the approval of synopsis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Diagnosed patients of 50-80 years of age
- Grade 2 \& 3 (frozen and thawing) adhesive capsulitis
- patients willing to participate in the study
- Only diabetic patients
You likely can't join if
- Major mental health probleme
- Patients who has a history of surgery on the shoulder, other shoulder diseases including a rotator cuff tear, sub acromial impingement syndrome, and...
- Patients taking oral or intra-articular steroids and cortisone injection prior 3 months
- people with rotator cuff tears or other shoulder ligament injuries, H/O arthritis related to shoulder, malignancy, adhesive capsulitis secondary to...
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.